Deborah Lehrich
Hematology & Oncology · Lumberton, NCNPI 1326004490
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,695 of the $2,193 with a category attached, or 77.3%. It is spread thinly across 34 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.
Across 83 payments — averaging $26.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$210
- Seagen Inc.$199
- Pfizer$171
- Incyte Corporation$170
- AVEO Pharmaceuticals, Inc.$156
- Merck$139
- plus $1K from 28 others
What the payments were for
- Food & beverage$1,69577%
- Education$49823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $210 |
| Seagen Inc. | 2 | $199 |
| Pfizer | 11 | $171 |
| Incyte Corporation | 4 | $170 |
| AVEO Pharmaceuticals, Inc. | 3 | $156 |
| Merck | 6 | $139 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Astellas Pharma US Inc | 4 | $92 |
| Bayer | 4 | $81 |
| Caris MPI, Inc. | 2 | $71 |
| AstraZeneca | 3 | $61 |
| GSK | 2 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Tersera Therapeutics LLC | 3 | $47 |
| Geron Corporation | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Sobi, Inc | 2 | $44 |
| Array Biopharma Inc | 2 | $40 |
| Eisai Inc. | 2 | $39 |
| Bristol Myers Squibb | 2 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| CSL Behring | 1 | $31 |
| Beone Medicines USA, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $29 |
| Pharmaand GmbH | 2 | $28 |
| Pharmaessentia USA Corporation | 1 | $28 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Tolmar, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Sanofi | 1 | $20 |
| Novartis | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
How this compares
$2,193 in reported general payments places this provider in the 50th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Lumberton
- Amit MehtaCary$4.3M
- Michael MorseDurham$2.6M
- Shelbi AtrashCharlotte$994K
- Phillip FebboDurham$749K
- Angela AlistarWinston Salem$509K
- Ravi PaluriWinston Salem$314K
- Matthew McKinneyDurham$277K
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
- Taewoong ChoiDurham$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.